A case of protracted eosinopenia after a single subcutaneous dose of benralizumab.
作者信息
Miranda Joana, Plácido José Luís, Amaral Luís
机构信息
Serviço de Imunoalergologia, Centro Hospitalar Universitário de São João E.P.E, Porto, Portugal.
Porto, Portugal.
出版信息
Allergo J Int. 2022 Sep 27:1-2. doi: 10.1007/s40629-022-00227-4.
Abstract
摘要
相似文献
1
A case of protracted eosinopenia after a single subcutaneous dose of benralizumab.单次皮下注射贝那利珠单抗后出现持续性嗜酸性粒细胞减少症一例。
Allergo J Int. 2022 Sep 27:1-2. doi: 10.1007/s40629-022-00227-4.
2
Benralizumab: an updated treatment of eosinophilic asthma.贝那利珠单抗：一种更新的嗜酸性粒细胞性哮喘治疗方法。
Expert Rev Respir Med. 2020 May;14(5):435-444. doi: 10.1080/17476348.2020.1739526. Epub 2020 Mar 17.
3
Anti-IL5 therapies for asthma.用于哮喘的抗白细胞介素-5疗法。
Cochrane Database Syst Rev. 2017 Sep 21;9(9):CD010834. doi: 10.1002/14651858.CD010834.pub3.
4
Asthma Control, Airway Mucus, and Xe MRI Ventilation After a Single Benralizumab Dose.单次 benralizumab 给药后哮喘控制、气道黏液和 Xe MRI 通气。
Chest. 2022 Sep;162(3):520-533. doi: 10.1016/j.chest.2022.03.003. Epub 2022 Mar 10.
5
Spontaneous resolution of atopic dermatitis incidental to participation in benralizumab clinical trial for severe, uncontrolled asthma: a case report.特应性皮炎在参加贝那鲁肽治疗重度未控制哮喘临床试验中自发缓解：一例报告。
J Med Case Rep. 2021 Mar 6;15(1):103. doi: 10.1186/s13256-021-02663-2.
6
COVID-19 in a Patient With Severe Eosinophilic Asthma on Benralizumab Therapy: A Case Report and Review of Literature.接受倍利珠单抗治疗的重度嗜酸性粒细胞性哮喘患者的COVID-19：病例报告及文献综述
Cureus. 2021 Dec 23;13(12):e20644. doi: 10.7759/cureus.20644. eCollection 2021 Dec.
7
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis.贝那鲁肽对伴有嗜酸性粒细胞肉芽肿伴多血管炎的严重嗜酸性粒细胞性哮喘加重的快速作用。
BMC Pulm Med. 2021 Jan 21;21(1):35. doi: 10.1186/s12890-021-01397-7.
8
Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.血清 IgE 浓度预测重度嗜酸性粒细胞性哮喘患者恶化风险和 benralizumab 疗效的能力。
Adv Ther. 2020 Feb;37(2):718-729. doi: 10.1007/s12325-019-01191-2. Epub 2019 Dec 14.
9
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.贝那利珠单抗，一种抗白细胞介素 5 受体 α 单克隆抗体，与安慰剂相比用于治疗未控制的嗜酸性粒细胞性哮喘：一项 2b 期随机剂量范围研究。
Lancet Respir Med. 2014 Nov;2(11):879-890. doi: 10.1016/S2213-2600(14)70201-2. Epub 2014 Oct 8.
10
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.贝那鲁肽在重度嗜酸性哮喘中的真实世界疗效。
Chest. 2021 Feb;159(2):496-506. doi: 10.1016/j.chest.2020.08.2083. Epub 2020 Aug 31.
引用本文的文献
1
Eosinophil granulocytes in chronic inflammatory respiratory diseases and CRSwNP: Function, immunological basis, and clinical significance.慢性炎症性呼吸道疾病和慢性鼻窦炎伴鼻息肉中的嗜酸性粒细胞：功能、免疫基础及临床意义
Allergol Select. 2024 Mar 21;8:40-50. doi: 10.5414/ALX02469E. eCollection 2024.
2
EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP).嗜酸性肉芽肿性多血管炎（查格-斯特劳斯综合征）：作为伴鼻息肉的慢性鼻-鼻窦炎（CRSwNP）的一种特殊表现形式。
Allergol Select. 2024 Mar 21;8:18-25. doi: 10.5414/ALX02475E. eCollection 2024.
本文引用的文献
1
Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis.贝那鲁肽对伴有嗜酸性粒细胞肉芽肿伴多血管炎的严重嗜酸性粒细胞性哮喘加重的快速作用。
BMC Pulm Med. 2021 Jan 21;21(1):35. doi: 10.1186/s12890-021-01397-7.
2
MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.MEDI-563，一种人源化抗白细胞介素-5 受体 α mAb，具有增强的抗体依赖性细胞介导的细胞毒性功能。
J Allergy Clin Immunol. 2010 Jun;125(6):1344-1353.e2. doi: 10.1016/j.jaci.2010.04.004.
3
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma.在一项针对轻度哮喘患者的 I 期研究中，抗 IL-5 受体 α 抗体 MEDI-563 的安全性特征、药代动力学和生物学活性。
J Allergy Clin Immunol. 2010 Jun;125(6):1237-1244.e2. doi: 10.1016/j.jaci.2010.04.005.
4
The eosinophil.嗜酸性粒细胞。
Annu Rev Immunol. 2006;24:147-74. doi: 10.1146/annurev.immunol.24.021605.090720.
5
Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.嗜酸性粒细胞的作用仍不明确，因为抗白细胞介素-5仅能部分减少哮喘气道中的嗜酸性粒细胞数量。
Am J Respir Crit Care Med. 2003 Jan 15;167(2):199-204. doi: 10.1164/rccm.200208-789OC. Epub 2002 Oct 17.
Zotero 插件